Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.27 SEK | -2.16% | -7.72% | -38.65% |
Apr. 26 | Q-Linea AB Receives FDA 510(k) Clearance for the ASTar® System | CI |
Mar. 13 | Q-linea AB Presents Strong ASTar Results At AMCLI | CI |
Sales 2024 * | 60.55M 5.59M | Sales 2025 * | 167M 15.4M | Capitalization | 271M 25.02M |
---|---|---|---|---|---|
Net income 2024 * | -191M -17.63M | Net income 2025 * | -146M -13.48M | EV / Sales 2024 * | 2.28 x |
Net cash position 2024 * | 133M 12.29M | Net Debt 2025 * | 5.24M 484K | EV / Sales 2025 * | 1.66 x |
P/E ratio 2024 * |
-1.91
x | P/E ratio 2025 * |
-2.83
x | Employees | 127 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.61% |
Latest transcript on Q-linea AB
1 day | -2.16% | ||
1 week | -7.72% | ||
Current month | -12.52% | ||
1 month | +7.08% | ||
3 months | -9.56% | ||
6 months | -26.77% | ||
Current year | -38.65% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 70 | 23-04-30 | |
Henrik Jacobsson
COO | Chief Operating Officer | 55 | 21-12-31 |
Chief Tech/Sci/R&D Officer | 48 | 19-07-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 62 | 11-12-31 | |
Founder | 54 | 08-03-31 | |
Director/Board Member | 70 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 2.27 | -2.16% | 189 332 |
24-05-08 | 2.32 | -1.49% | 217,014 |
24-05-07 | 2.355 | +5.13% | 415,922 |
24-05-06 | 2.24 | -8.94% | 431,418 |
24-05-03 | 2.46 | -3.72% | 335,347 |
Delayed Quote Nasdaq Stockholm, May 10, 2024 at 11:29 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.65% | 24.95M | |
-16.33% | 18.83B | |
-42.88% | 2.92B | |
+22.02% | 1.9B | |
+0.39% | 1.71B | |
+27.15% | 1.26B | |
-10.70% | 1.04B | |
-18.27% | 961M | |
+0.66% | 779M | |
-25.37% | 649M |
- Stock Market
- Equities
- QLINEA Stock